Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |